Location: Home
  • search
  • go
  • Relate News
  • 3/20/2024China Offers Huge Weight-loss Drug Market Potential for Novo Nordisk a...
  • 3/20/2024China Ranked Top Potential Biopharma Outsourcing Destination (Bioproce...
  • 3/19/2024Genscript Losses Shrink on Strong Growth for Cancer Cell Therapy (Bamb...
  • 3/19/2024Perspectives on 2024's Two Sessions (NCUSCR)
  • 3/19/2024China to Expand Pilot Program for Medical Services Pricing Reform
  • 3/19/2024NDRC Issues 2024 Edition of the Guiding Catalog for Adjustment of Indu...
  • 3/19/2024Zuellig Pharma and Karo Healthcare strengthen partnership across key m...
  • 3/19/2024Novo Nordisk Invests CNY 4B Into Flagship Tianjin Plant Expansion Ahea...
  • 3/19/2024China Issues New Document on Advancing Physician Electronic Informatio...
  • 3/19/2024Challenges in Accessing Paxlovid Amidst Rising COVID-19 Cases in China
  • 3/18/2024Bio-Thera Solutions Partners with SteinCares to Market Two Biosimilars...
  • 3/18/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (80...
  • 3/18/2024The US and Chinese Biopharma Contractors (Science)
  • 3/15/2024Major Life Sciences Licensing Deal Trends in China in 2023 (Supra)
  • 3/15/2024Chinese Pharma Stocks Surge amid Speculation of Government Support for...
  • 3/15/2024Biotheus and Hansoh Pharma Expand ADC Collaboration
  • 3/15/2024Unveiling Quality of Clinical Trial in China: from Concern to Confirma...
  • 3/15/2024Recent Executive Moves
  • 3/15/2024Drug R&D and Product Registration News Digest March 2024 (2)
  • 3/14/2024Sinohealth: Review of Chinese Retail Pharmacy Drug Sales and Top 20 Pr...
  • 3/14/2024PhIIC: Review of Prescription Drug Sales Trends in Chinese Retail Phar...
  • 3/13/2024IQVIA: Chinese Hospital Drug Market Rose 4.2% in 2023 (MAT Q4/2023)
  • 3/13/2024Biotech Lobby Group BIO to Sever Ties with WuXi Amid National Security...
  • 3/13/2024WuXi Became a Critical Partner to Biopharma Companies. They're Not Rea...
  • 3/13/2024Navigating China's Biologics Approval And Accelerated Pathways (Clinic...
  • 3/12/2024Global Pharmaceutical Investment in Asia: A Strategic Focus Amidst Evo...
  • 3/12/2024CDE Issues the List of Reference Formulations for GQCE Studies (78th B...
  • 3/12/2024BIO Faces Criticism for Involvement in Legislation Concerning China's ...
  • 3/11/2024Johnson & Johnson Completes Acquisition of Ambrx
  • 3/11/2024Startups Raised Millions to In-license Drugs to China. Then the Model ...
  • Page:5/709 Total number of articles:21268: [First][<<] [3] [4] [5] [6] [7] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group